Anum Shahzad, MD
Cardiovascular Disease · Aurora, CONPI 1285163576
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,375 of the $1,669 with a category attached, or 82.4%. It is spread thinly across 16 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $541 and has fallen 96.5% since, to $19 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CO, where the typical reported total is $1,537.
Across 51 payments — averaging $32.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$365
- Abbott$269
- Impulse Dynamics (USA) Inc.$259
- AstraZeneca$137
- E.r. Squibb & Sons, L.L.C.$121
- Astellas Pharma US Inc$99
- plus $420 from 10 others
What the payments were for
- Food & beverage$1,37582%
- Education$29418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 17 | $365 |
| Abbott | 5 | $269 |
| Impulse Dynamics (USA) Inc. | 6 | $259 |
| AstraZeneca | 2 | $137 |
| E.r. Squibb & Sons, L.L.C. | 7 | $121 |
| Astellas Pharma US Inc | 1 | $99 |
| Abiomed | 2 | $78 |
| Boston Scientific | 1 | $74 |
| Altathera Pharmaceuticals LLC | 1 | $69 |
| Heartflow, Inc. | 2 | $55 |
| Novartis | 1 | $41 |
| Irhythm Technologies, Inc. | 1 | $31 |
| Merck | 2 | $26 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$286
- Optis Coronary Imaging System$156
- FARXIGA$125
How this compares
$1,669 in reported general payments places this provider in the 50th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 26 | $232 |
| Ezetimibe | 11 | $213 |
| Atorvastatin Calcium | 20 | $118 |
| Rosuvastatin Calcium | 11 | $74 |
| Losartan Potassium | 14 | $58 |
| Spironolactone | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Aurora
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- William SauerAurora$365K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Edward GillAurora$96K
- Joseph AdewumiAurora$61K
- Charles FuenzalidaAurora$30K
- Christina HealyAurora$25K
- Sundeep ViswanathanAurora$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.